The Genomics Institute of the Novartis Research Foundation (GNF) in San Diego reached a major milestone in April with US FDA approval for the lung cancer drug Zykadia (ceritinib), because it was the first FDA approval for a compound discovered at GNF.
Zykadia also is the first drug approved in the US for patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung...


![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

